1. Assessment of the ability of the Privigen® purification process to deplete thrombogenic factor XIa from plasma. Issue 1 (13th December 2013) Authors: Komenda, M.; Stadler, D.; Malinas, T.; Moses, M.; Pragst, I.; Herzog, E.; Schmutz, P.; Minnig, K.; El Menyawi, I. Journal: Vox sanguinis Issue: Volume 107:Issue 1(2014) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa‐FP). (February 2014) Authors: Zollner, S.; Schuermann, D.; Raquet, E.; Mueller‐Cohrs, J.; Weimer, T.; Pragst, I.; Dickneite, G.; Schulte, S. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 2(2014:Feb.) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗